INBS INTELLIGENT BIO SOLUTIONS INC.
Nasdaq · SEC CIK 1725430 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 57 since 2021-09-22, latest 2026-03-20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Fraser Nicola Marion | Dir | — | — |
| Isenberg Jason | Dir | — | — |
| Simeonidis Harry | CEO | — | — |
| Sakiris Spiro Kevin | CFO | — | — |
| Hurd Jonathan Scott | Dir | — | — |
| Boyages Steven Constantine | Dir | — | — |
Transactions 56
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-20 | 2026-03-18 | INBS | Sakiris Spiro Kevin | CFO | A - Grant | $0.00 | +30.5K | 34.0K | +876% | $0 |
| 2026-03-20 | 2026-03-18 | INBS | Fraser Nicola Marion | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 | |
| 2026-03-20 | 2026-03-18 | INBS | Hurd Jonathan Scott | Dir | A - Grant | $0.00 | +5,000 | 5,006 | +83,333% | $0 | |
| 2026-03-20 | 2026-03-18 | INBS | Boyages Steven Constantine | Dir | A - Grant | $0.00 | +5,000 | 5,031 | +16,129% | $0 | |
| 2026-03-20 | 2026-03-18 | INBS | Isenberg Jason | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 | |
| M | 2026-03-20 | 2026-03-18 | INBS | Simeonidis Harry | CEO | A - Grant | $0.00 | +30.5K | 34.5K | +755% | $0 |
| A | 2025-03-31 | 2024-09-25 | INBS | Sakiris Spiro Kevin | CFO | A - Grant | $0.00 | +34.5K | 34.8K | +10,952% | $0 |
| 2024-09-27 | 2024-09-25 | INBS | Simeonidis Harry | CEO | A - Grant | $0.00 | +40.0K | 40.4K | +9,804% | $0 | |
| 2024-09-27 | 2024-09-25 | INBS | Sakiris Spiro Kevin | CFO | A - Grant | $0.00 | +34.5K | 34.8K | +10,952% | $0 | |
| DI | 2024-03-21 | 2024-03-20 | INBS | Sakiris Spiro Kevin | CFO | X - OptEx | — | +9,394 | 19.2K | +96% | — |
| D | 2023-10-06 | 2023-10-04 | INBS | TOWERS CHRISTOPHER | Dir | P - Purchase | — | +9,090 | 9,880 | +1,151% | — |
| DI | 2023-10-06 | 2023-10-04 | INBS | Sakiris Spiro Kevin | CFO | P - Purchase | — | +112.7K | 117.4K | +2,398% | — |
| M | 2023-09-05 | 2023-08-31+ | INBS | Simeonidis Harry | CEO | P - Purchase | $1.90 | +150 | 4,130 | +4% | +$284.50 |
| DI | 2023-07-11 | 2023-05-10 | INBS | Sakiris Spiro Kevin | CFO | C - Cnv Deriv | $5.80 | +2,399 | 4,745 | +102% | +$13.9K |
| 2022-10-12 | 2022-10-10 | INBS | FISHER LAWRENCE B | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 | |
| 2022-10-12 | 2022-10-10 | INBS | Boyages Steven Constantine | COB, Interim CEO, Dir | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 | |
| 2022-10-12 | 2022-10-10 | INBS | TOWERS CHRISTOPHER | Dir | A - Grant | $0.00 | +15.0K | 15.8K | +1,875% | $0 | |
| 2022-10-12 | 2022-10-10 | INBS | Hurd Jonathan Scott | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 | |
| 2022-10-12 | 2022-10-10 | INBS | Simeonidis Harry | Pres | A - Grant | $0.00 | +80.0K | 80.6K | +13,333% | $0 | |
| 2022-10-12 | 2022-10-10 | INBS | Margelis George | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 | |
| 2022-10-12 | 2022-10-10 | INBS | Sakiris Spiro Kevin | CFO | A - Grant | $0.00 | +75.0K | 125.2K | +149% | $0 | |
| 2022-06-24 | 2022-06-22 | INBS | Sakiris Spiro Kevin | CFO | P - Purchase | $0.65 | +5,000 | 50.2K | +11% | +$3,250 | |
| 2022-06-22 | 2022-06-17 | INBS | Sakiris Spiro Kevin | ChiefFinancial Off | P - Purchase | $0.61 | +16.0K | 45.2K | +55% | +$9,742 | |
| 2022-02-22 | 2022-02-17 | INBS | Life Science Biosensor Diagnostics Pty Ltd | Former 10% owner | S - Sale | $0.51 | -576.0K | 1.08M | -35% | -$293.8K | |
| 2022-02-18 | 2022-02-16 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $0.63 | -100.0K | 1.66M | -6% | -$63.0K | |
| M | 2022-02-17 | 2022-02-11+ | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $0.71 | -300.0K | 1.96M | -13% | -$213.0K |
| 2022-02-15 | 2022-02-10 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $0.84 | -100.0K | 2.06M | -5% | -$84.0K | |
| 2022-02-11 | 2022-02-09 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $0.86 | -100.0K | 2.16M | -4% | -$86.0K | |
| 2022-02-10 | 2022-02-08 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $0.89 | -100.0K | 2.26M | -4% | -$89.0K | |
| 2022-02-08 | 2022-02-02 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $0.92 | -100.0K | 2.36M | -4% | -$92.0K | |
| 2022-02-03 | 2022-01-31 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $0.9 | -100.0K | 2.46M | -4% | -$90.0K | |
| 2022-02-01 | 2022-01-27 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $1.00 | -100.0K | 2.66M | -4% | -$100.0K | |
| 2022-02-01 | 2022-01-28 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $0.92 | -100.0K | 2.56M | -4% | -$92.0K | |
| 2022-01-03 | 2021-12-30 | INBS | Parmakellis Tom | Dir | P - Purchase | $1.55 | +4,500 | 9,300 | +94% | +$6,975 | |
| 2021-12-21 | 2021-12-17 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $1.49 | -200.0K | 2.76M | -7% | -$298.0K | |
| 2021-12-20 | 2021-12-16 | INBS | Parmakellis Tom | Dir | P - Purchase | $1.69 | +2,800 | 4,800 | +140% | +$4,732 | |
| 2021-12-07 | 2021-12-06 | INBS | Sakiris Spiro Kevin | ChiefFinancial Off | P - Purchase | $1.70 | +10.0K | 29.3K | +52% | +$17.0K | |
| 2021-12-03 | 2021-11-30 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $1.87 | -250.0K | 2.96M | -8% | -$467.5K | |
| 2021-12-01 | 2021-11-29 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $1.69 | -100.0K | 3.21M | -3% | -$169.0K | |
| 2021-11-29 | 2021-11-24 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $1.64 | -100.0K | 3.31M | -3% | -$164.0K | |
| 2021-11-12 | 2021-11-09 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.02 | -300.0K | 3.41M | -8% | -$606.0K | |
| 2021-10-25 | 2021-10-21 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.26 | -248.4K | 3.71M | -6% | -$561.4K | |
| 2021-10-22 | 2021-10-20 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.25 | -24.2K | 3.96M | -0.6% | -$54.5K | |
| 2021-10-21 | 2021-10-19 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.25 | -16.3K | 3.98M | -0.4% | -$36.7K | |
| 2021-10-18 | 2021-10-14 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.18 | -100.7K | 4.00M | -2% | -$219.6K | |
| 2021-10-15 | 2021-10-13 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.25 | -58.7K | 4.10M | -1% | -$132.2K | |
| 2021-10-14 | 2021-10-12 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.13 | -100.0K | 4.16M | -2% | -$213.0K | |
| 2021-10-12 | 2021-10-08 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.30 | -200.0K | 4.26M | -4% | -$460.0K | |
| 2021-09-30 | 2021-09-28 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.48 | -200.0K | 4.46M | -4% | -$496.0K | |
| 2021-09-30 | 2021-09-28 | INBS | Parmakellis Tom | Dir | P - Purchase | $2.40 | +1,000 | 2,000 | +100% | +$2,400 | |
| 2021-09-28 | 2021-09-24 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.66 | -200.0K | 4.66M | -4% | -$532.0K | |
| 2021-09-27 | 2021-09-23 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.77 | -100.0K | 4.86M | -2% | -$277.0K | |
| 2021-09-24 | 2021-09-22 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.80 | -100.0K | 4.96M | -2% | -$280.0K | |
| 2021-09-23 | 2021-09-21 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.83 | -100.0K | 5.06M | -2% | -$283.0K | |
| 2021-09-22 | 2021-09-17 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $3.29 | -45.2K | 5.26M | -0.9% | -$148.6K | |
| 2021-09-22 | 2021-09-20 | INBS | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.90 | -100.0K | 5.16M | -2% | -$290.0K |
Purchase Sale Sale after option exercise All abbreviations